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1. INTRODUCTION 
1.1. An introduction about infection 
An infection is caused by the invasion of foreign cells, like bacteria in humans 
that cause harm to the host organism. Generally the host organism is considered 
“colonized” by cells that don’t belong to it. These foreign cells must be harmful to the 
host organism in order for the colonization to be considered an infection1. 
Numerous agents can cause an infection. Not only bacteria, but also viruses, 
parasites, and fungi can create problems for a host organism. Sometimes these non-
host cells actually work in conjunction to keep infection from occurring. 
Infectious diseases, also known as transmissible diseases or communicable 
diseases, comprise clinically evident illness (i.e., characteristic medical signs and/or 
symptoms of disease) resulting from the infection, presence and growth of pathogenic 
biological agents in an individual host organism. In certain cases, infectious diseases 
may be asymptomatic for much or even all of their course in a given host. In the latter 
case, the disease may only be defined as a "disease" (which by definition means an 
illness) in hosts who secondarily become ill after contact with an asymptomatic 
carrier. An infection is not synonymous with an infectious disease, as some infections 
do not cause illness in a host. 
Infectious diseases are sometimes called "contagious" when they are easily 
transmitted by contact with an ill person or their secretions (e.g., influenza). Thus, a 
contagious disease is a subset of infectious disease that is especially infective or easily 
transmitted.  
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1. The main micro organisms causing infections are as follows 2  
Name Living Conditions  Examples  Prevention  Cure 
VIRUSES  Unable to live outside other cells. May infect 
prokaryotes and/or eukaryotes. Replicates inside 
host cell by coding (with viral nucleic acid) for 
new viral synthesis there.  
Bacteriophages, Plant mosaic 
viruses, HIV, Herpes, Influenza, 
Hepatitis  
Good personal 
hygiene. Some 
immunization(e.g. 
'flu, polio)  
 
NOT antibiotics. 
Immune system fights 
viruses. Recently, some 
antiviral drugs are 
developed. 
BACTERIA Ubiquitous. In almost all environmental niches. 
Most are non pathogens. Pathogenic bacteria: 
Cause disease in eukaryotes. Classified by shape 
(spheres, rods, spirals). Classified by chemistry 
(eg Gram +/-) Classified by structures (cilia, 
flagella) Some produce destructive toxins.  
Streptococcus, Salmonella, 
Staphylococcus, Escherichia coli (E. 
coli) Mycobacterium tuberculosis, 
Clostridium tetani 
Good personal 
hygiene. 
Immunisation (e.g. 
TB), Public 
sanitation, Surgical 
aseptic techniques. 
Various antibiotics. 
(1928 Fleming 
discovered penicillin, 
1938 Florey developed it 
for human use.) Anti-
toxins (e.g. tetanus)  
3 
FUNGI Yeasts - Unicellular, divide by binary fission or 
budding. Can exist as spores.Moulds - Filamentous 
mat of thread-like hyphae produces a mycelium. 
Fruiting bodies produce spores. (Some pathogenic 
fungi can exist as either of the above forms, 
depending on the environment.)  
Candida (-> thrush) 
Trichophyton (-> tinea) 
Aspergillus (-> pneumonia 
or asthma)  
Good personal hygiene.  Various anti-
fungal drugs.  
PARASITES Either ectoparasites (outer surfaces of host) or 
endoparasites (inside host's body). Many have 
complex life cycles which include a period away 
from humans and a time in or on humans. Many 
have specialised structures for attachment to 
humans either to prevent dislodgment or obtain 
nutrients or both. VECTOR = living transmitter of 
disease (e.g. mosquito -> malaria) RESERVOIR = 
source of parasite in biotic environment (e.g. 
contaminated soil or water).  
Malaria, Dysentery, Liver 
fluke, Intestinal worms, 
Schistoma, Fleas, Ticks, 
Lice  
Good personal hygiene.Public 
sanitation.Break life-
cycle.Cook meat before eating. 
Some 
insecticides. 
Some 
drugs.Surgery to 
remove 
cysts.Topical 
insecticides.  
 26 
 
1.2 Epidemiology of Infection 2 
When bacteria infect an ordinarily sterile site, they present a serious medical condition, 
even if they are not resistant to hosts, including other hospital patients, hospital workers, family 
members, or schoolmates. The relative importance of these host reservoirs as a source of 
infection probably declines as a function of proximity to the focal host; the most likely sources 
are the patients themselves, followed by health care workers, other hospital patients, and family 
members. The bacteria are transmitted by direct contact, such as touching or sneezing, or indirect 
contact through an intermediate contaminated object. For example, health care workers can be 
carriers, or they may be vectors who move bacteria among patients or from contaminated objects 
in a patient’s room. The objects that surround individuals, including furniture and food and 
water, can become contaminated. Medical devices area particularly important source of 
infections: they bring a potentially contaminated surface into contact with living tissue. One 
problem with medical devices is that their wet surfaces facilitate the growth of biofilms which 
can help facilitate gene exchange and persistence, protect bacteria from antibiotics, and so 
provide a natural refuge and gentle exposure that may become important in the evolution of 
resistance. A potential source of antibiotic resistance in environmental bacteria is the sewage 
effluent from hospitals and long-term care facilities, which contains large numbers of resistant 
bacteria. Large amounts of antibiotics are also used in agriculture for prophylaxis or as 
nutritional supplements, and antibiotic-resistant bacteria can remain in meat through the abattoir 
and retail (Witte 1998). Most meat is properly cooked in the home or in restaurants, but 
uncooked meat can cross-contaminate raw foods during preparation. This is a potentially 
important source of exposure and perhaps colonization. Like hospital sewage, the effluent from 
farms that use antibiotics can be a source of antibiotic-resistant bacteria in the environment. 
 27 
 
1.3 Surgical site infection (SSI) 3 
Definition 
Surgical site infections defined as the infections that occur up to 30 days after surgery (or up to 
one year after surgery in patients receiving implants) and affecting either the incision or deep 
tissue at the operation site. Despite improvements in prevention, SSIs remain a significant 
clinical problem as they are associated with substantial mortality and morbidity and impose 
severe demands on healthcare resources. The incidence of SSIs may be as high as 20%, 
depending on the surgical procedure, the surveillance criteria used, and the quality of data 
collection. In many SSIs, the responsible pathogens originate from the patient's endogenous 
flora. The causative pathogens depend on the type of surgery; the most commonly isolated 
organisms are Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus spp. and 
Escherichia coli. Numerous patient-related and procedure-related factors influence the risk of 
SSI, and hence prevention requires a ‘bundle’ approach, with systematic attention to multiple 
risk factors, in order to reduce the risk of bacterial contamination and improve the patient's 
defences. The Centers for Disease Control and Prevention guidelines for the prevention of SSIs 
emphasise the importance of good patient preparation, aseptic practice, and attention to surgical 
technique; antimicrobial prophylaxis is also indicated in specific circumstances. Emerging 
technologies, such as microbial sealants, offer the ability to seal and immobilize skin flora for the 
duration of a surgical procedure; a strong case therefore exists for evaluating such technologies 
and implementing them into routine clinical practice as appropriate 
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Surgical site infections (SSIs) are linked to a major cause of patient injury and death and 
consume substantial health care resources. A large percentage of the number of surgical site 
infections (40% - 60%) is thought to be preventable and as such, characterized as a "never event" 
medical error. Surgical site infection rates have been cited in the literature as occurring in 2%-
5% of patients after clean extra-abdominal surgeries and up to 20% of patients undergoing intra-
abdominal procedures. It is difficult to identify nosocomial infections in patients who have been 
discharged. 
1.3.1 Classifications of Surgical Site Infections 4 
They are classified as either incisional or organ/space infections. Incisional infections are 
subdivided for those involving only the skin and subcutaneous tissue and for those involving 
deeper soft tissue. Surveillance can include reviewing patients receiving antibiotic therapy for 
any reason within the defined period of time after a surgical procedure. 
a) Superficial Incisional Infections: 
Infection involving only the skin or subcutaneous tissue of the incision and one or more of the 
following: 
¾ Purulent drainage from the superficial incision with or without laboratory confirmation. 
¾ Organisms confirmed by culture from either an aseptically fluid or tissue from the 
superficial incision.  
¾ One or more signs of infection (pain/tenderness, localized swelling, redness or heat) and 
the superficial incision are deliberately opened by the surgeon unless the incision is 
culture-negative. 
¾ A surgeon or attending physician diagnoses a superficial incision surgical site infection. 
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b) Deep Incisional Infections:  
Infection involving deep soft tissue of the incision such as facial and muscle layers and one or 
more of the following: 
¾ Purulent drainage from the deep incision but not from the organ or space component of 
the surgical site. 
¾ The deep incision spontaneously separates or is deliberately opened by a surgeon 
when the patient has one or more of the signs of infection (fever over 38ºC, localized pain 
or tenderness) unless the site is culture-negative. 
¾ A surgeon or attending physician diagnoses a deep incision surgical site infection. 
c) Organ/Space Infections 
Involves any part of the body, for example organs or spaces, other than the incision, which was 
opened or manipulated during the procedure and one or more of the following: 
¾ Purulent drainage from a drain that is placed through a stab wound into the organ/ space. 
¾ Organisms confirmed by culture from either an aseptically obtained fluid or tissue from 
the organ/space. 
1.3.2. Epidemiology of surgical site infection5 
Surgical site infections contribute significantly to the morbidity and mortality of the individual 
patient and impose a burden on the health care resources of the community. With the shift 
toward streamlined hospitalizations and ambulatory surgery, a majority of surgical site infections 
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are being diagnosed after discharge. There are several tools available for identifying and risk 
stratifying patients that include the National Nosocomial Infections Surveillance system and the 
Study on the Efficacy of Nosocomial Infection Control index. If patients can be identified 
preoperatively, appropriate prophylactic measures and post discharge surveillance can be 
undertaken, an underemphasized task faced by hospital systems today. 
Surgical site infections are the third most common health care–associated infection, accounting 
for 14% to 16% of these infections in all patients. These complications result in 3.7 million 
excess hospital days and $1.6 billion in extra charges From 1992 to 1998, the NNIS (National 
Nosocomial Infections Surveillance) recorded 738,393 operations performed in participating 
hospitals with 19,267 SSIs documented for 44 procedure categories, with the timing of the 
diagnosis documented in 14,949 of these patients Interestingly, 54% of these patients were 
diagnosed after discharge   
1.4. Antibiotics 6,7 
Antibiotics are chemical compounds used to kill or inhibit the growth of bacteria. Strictly 
speaking, antibiotics are a subgroup of organic anti-infective agents that are derived from 
bacteria or moulds that are toxic to other bacteria. However, the term antibiotic is now used 
loosely to include anti-infectives produced from synthetic and semi synthetic compounds.  
The term antibiotic may be used interchangeably with the term antibacterial. However, it is 
incorrect to use the term antibiotic when referring to antiviral, antiprotozoal and antifungal 
agents.  
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Fig.1.General mechanism of antibiotics  
 
 
2. Classification of antibiotics based on mechanism 
Table 2.Classification of antibiotics based on mechanism 
Antibiotic Grouping By Mechanism
Cell Wall Synthesis Penicillins 
Cephalosporins 
Vancomycin 
Beta-lactamase Inhibitors 
Carbapenems 
Aztreonam 
Polymycin 
Bacitracin 
Protein Synthesis Inhibitors Inhibit 30s Subunit 
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Aminoglycosides (gentamicin) 
Tetracyclines 
Inhibit 50s Subunit 
Macrolides 
Chloramphenicol 
Clindamycin 
Linezolid  
Streptogramins 
DNA Synthesis Inhibitors Fluoroquinolones  
Metronidazole 
RNA synthesis Inhibitors Rifampin 
Mycolic Acid synthesis inhibitors Isoniazid 
Folic Acid synthesis inhibitors Sulfonamides 
Trimethoprim 
 
  
Antibiotic Classification & Indications
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(bactericidal: blocks cross linking via competitive inhibition of the transpeptidase enzyme) 
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Above +  
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E. Coli** 
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producingStaph. 
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4th generation Moxifloxacin 
Gemifloxacin 
As above + Gram-
positives + 
anaerobes 
as above 
Other DNA Inhibitors
Metronidazole 
(bacteridical: metabolic 
biproducts disrupt DNA) 
Metronidazole (Flagyl) Anaerobics Seizures 
Crebelar 
dysfunction 
ETOH disulfram 
reaction 
RNA Synthesis Inhibitors
Rifampin 
(bactericidal: inhibits 
RNA transcription by 
inhibiting RNA 
polymerase) 
Rifampin Staphylococcus 
Mycobacterium (TB
)  
Body fluid 
discoloration 
Hepatoxicity 
(with INH) 
Mycolic Acids Synthesis Inhibitors
Isoniazid Isoniazidz TB 
Latent TB 
  
Folic acid Synthesis Inhibitors 
Trimethoprim/Sulfonam
ides 
(bacteriostatic: inhibition 
with PABA) 
Trimethoprim/Sulfamethoxa
zole (SMX) 
Sulfisoxazole 
Sulfadiazine 
UTI organisms 
Proteus 
Enterobacter 
Thrombocytopen
ia 
Avoid in third 
trimester of 
pregnancy 
Pyrimethamine Pyrimethamine Malaria 
T. gondii 
  
 
1.4.2. Classification of antibiotics based on structure 8 
Antibiotics can be classified in several ways. The most common method classifies them 
according to their chemical structure as antibiotics sharing the same or similar chemical structure 
will generally show similar patterns of antibacterial activity, effectiveness, toxicity and allergic 
potential. 
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Table 3. Classification of antibiotics based on structure 
Class (Based on 
chemical structure)       Mechanism of action        Examples  
Beta - lactam antibiotics 
Penicillin 
Cephalosporins 
Carbapenems 
Inhibit bacterial cell wall synthesis  Penicillin  
• Penicillin G  
• Amoxicillin  
• Flucloxacillin  
Cephalosporins  
• Cefoxitin  
• Cefotaxime  
• Ceftriaxone  
Carbapenem  
• Imipenem  
Macrolides  Inhibit bacterial protein synthesis  • Erythromycin  
• Azithromycin  
• Clarithromycin  
Tetracyclines  Inhibit bacterial protein synthesis  • Tetracycline  
• Minocycline  
• Doxycycline  
• Lymecycline  
Fluoroquinolones  Inhibit bacterial DNA synthesis  • Norfloxacin  
• Ciprofloxacin  
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• Enoxacin  
• Ofloxacin  
Sulphonamides  Blocks bacterial cell metabolism by 
inhibiting enzymes  
• Co-trimoxazole  
• Trimethoprim  
Aminoglycosides  Inhibit bacterial protein synthesis  • Gentamicin  
• Amikacin  
Imidazoles  Inhibit bacterial DNA synthesis  • Metronidazole  
Peptides  Inhibit bacterial cell wall synthesis  • Bacitracin  
Lincosamides  Inhibit bacterial protein synthesis  • Clindamycin  
• Lincomycin  
Other  Inhibit bacterial protein synthesis  • Fusidic acid  
• Mupirocin  
 
1.5. Antibiotic Resistance 9 
The overuse and inappropriate use of antibiotics has led to antibiotic resistance. Bacteria 
that were once susceptible to antibiotics have developed ways to survive the drugs that were 
meant to kill or weaken them. This is also known as antibacterial resistance or drug resistance. 
Some diseases such as tuberculosis, gonorrhea and childhood bacterial ear infections that were 
once easily treated with antibiotics are now again becoming difficult to treat as bacteria have 
become resistant to these drugs. About 70% of bacteria that cause infections in hospitals are 
resistant to at least one of the antibiotics most commonly used to treat infections. Methicillin 
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(meticillin) resistant Staphylococcus aureus (MRSA) is a particular problem for patients with 
skin diseases, ulcers and surgical wounds.  Antibiotic resistance is becoming a cause for 
increasing concern and is the most common cause of treatment failure in bacterial infections 
diseases. Antibiotic resistance is classified into two broad types. 
a) Intrinsic: This type is also known as innate. In this type the inherent properties of the 
bacterium are responsible for preventing antibiotic action. This is always chromosomally 
mediated. 
b) Acquired: This occurs when bacteria which were previously susceptible become resistant, 
usually, but not always, after exposure to the antibiotic concerned. This occurs by 
mutation in the chromosome. 
1.5.1. Epidemiology of Antibiotic Resistance10 
Antibiotic resistance is the inevitable consequence of antibiotic use. This has been a 
painful lesson for virtually all treatable microbes, including all major categories: bacteria, fungi, 
viruses, and parasites. In general, there needs to be a sharp distinction between the resistance 
problems in the health care setting (nosocomial infections) and those encountered in the 
community (community-acquired infections) based on vast differences in pathogens and 
resistance patterns. Nevertheless, there has recently been the development of a hybrid form, 
referred to as "healthcare-associated infections" in reference to patients who have frequent 
contact with the medical care system, as with a chronic care facility or on outpatient basis. A 
fundamental principle is the concept that in all settings, extensive use of antibiotics will lead to 
resistance ("use it and lose it"). Despite the rule, history has taught that we have great difficulty 
in predicting evolutionary patterns of resistance.  
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This review will concentrate on practical issues for consideration by primary care 
physicians for their role in the prevention of resistance in theimanagementofcommunity-
acquired acute respiratory infections.To respond to this threat, World Health Organisation has 
developed the first Global Strategy for Containment of Antimicrobial Resistance.Strategies for 
decreasing antibiotic resistance include: 
1. Use narrow spectrum agents. 
2. Do not use antibiotics for non-infections. 
3. Use short courses and at correct time. 
4. Avoid usage of last line antibiotics for serious infection and use only where       
simple agents would be ineffective. 
5. Education about antibiotic usage to health care professionals and general public    
use antibiotic sensitivity profiles and antibiotic guidelines. 
6. Surveillance of antibiotic usage, quantities used and their resistance. 
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2. LITERATURE REVIEW 
1.  Musher et al11, conducted the sensitivity study of 105 patients with pneumococcal pneumonia 
proven by blood culture. Gram staining revealed gram-positive cocci in pairs and chains, and 
culture yielded pneumococci in only 31% and 44% of all cases, respectively. However, sputum 
specimens were never submitted for examination in 31 cases; in 16 others, the specimen was 
inadequate and a culture was not done. Excluding these cases, the sensitivities of Gram staining 
and culture were 57% and 79%, respectively. If patients receiving antibiotics for >24 h had been 
excluded, Gram staining would have suggested pneumococci in 63%, and culture results would 
have been positive in 86%. Sensitivity increased in inverse proportion to the  duration of 
antibiotic therapy.Microscopic examination of sputum samples before antibiotics were 
administered and performance of culture within 24 h of receipt of such treatment yielded the 
correct diagnosis in >80% of cases of pneumococcal pneumonia 
2.  Annie12,  conducted a study  to prospectively evaluate empirical antimicrobial prescribing at a 
large university teaching hospital using the suggested outcome and process measurements. A 
total of 137 patients who received empirical therapy during the study were reviewed. Nearly half 
were prescribed empirical th erapy for surgical prophylaxis; the potential cost savings was $92 
per treatment course. Other areas of empirical therapy that resulted in increased expenditures, 
adverse effects, and super infections included continuation of empirical therapy despite negative 
culture results in 45 patients (37%) and failure to modify therapy based on culture and sensitivity 
results in 12 paients (9%). The study concluded  that  an  appropriate empirical therapy can lead 
to significant cost and negative outcomes.  
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3.  Gorden  et al13conducted a study to examine use of third-generation cephalosporins alone and 
in association with vancomycin hydrochloride as a risk factor for vancomycin-resistant 
Enterococcus (VRE) infection in surgical patients.  Surgical inpatients with vancomycin-resistant 
enterococcus infections between were matched with patients with vancomycin-sensitive 
enterococcus infections. Matches were based on surgical procedure, initial infection site, and 
immunosuppressant.Matches were  found for 32 of 50 surgical patients with vancomycin-
resistant enterococcus twenty matched pairs of patients were recipients of solid organ 
transplants. This matched control study showed that use of third-generation cephalosporins, 
alone or concurrently with vancomycin was a risk factor for vancomycin-resistant Enterococcus 
infection in surgical patients. Judicious administration of third-generation antibiotics is 
warranted in surgical patients with other risk factors for vancomycin-resistant Enterococcus  
4. Giacometti et al14, conducted a study that included 676 surgery patients with signs and 
symptoms indicative of wound infections, who presented over the course of 6 years. Bacterial 
pathogens were isolated from 614 individuals.A single etiologic agent  was identified in 271 
patients, multiple agents were found in 343, and no agent was identified in 62. A high 
preponderance of aerobic bacteria was observed. Among the common pathogens were  
Staphylococcus aureus  (191 patients, 28.2%), Pseudomonas aeruginosa  (170 patients, 25.2%),  
Escherichia coli (53 patients, 7.8%), Staphylococcus epidermidis  (48 patients, 7.1%), and  
Enterococcus faecalis (38 patients, 5.6%).The study concluded that there is a  high percentage of 
inappropriate use of antimicrobials raises concerns about the development and spread of drug 
resistance, which must be addressed. 
5.  Siguan et al15, conducted a prospective survey of the microbiological causes of surgical 
wound infection encountered in the Department of Surgery, Cebu Velez General Hospital. From 
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the 774 operations performed during the study, the overall infection rate was 7.8%. The most 
common aerobic organisms isolated were Staphylococcus aureus, Pseudomonas aeruginosa,  
Escherichia coli,Acinetobacter calcoaceticus,  Enterobactercloacaeand  Enterobacter 
agglomerans  comprising 80% of all isolates. The sensitivity and resistance patterns of the 
commonly used antibiotics were presented and convincingly showed a changing trend towards 
unsatisfactory drug performance 
6.  Deep et al16, conducted as study in Pediatric ICU of a teaching hospital to estimate the 
incidence of nosocomial infections, establish the clinical and bacteriological profile and identify 
probable exogenous source from the environment and personnel. 95 suspected cases of 
nosocomial infections were studied prospectively, identified as per the guidelines laid down by 
the Centre for Disease Control and Prevention.  The rate of nosocomial infections was 27.3% 
with an incidence of 16.2 per 100 patient days. The incidence of urinary, respiratory and 
intravascular catheter related infections was 56.52%, 34.78%, 10.52% respectively. Klebsiella 
(33.33%) was the most common isolate with maximum sensitivity to amikacin. During the study, 
an outbreak of methillin resistant staphylococcus aureus nosocomial infection was encountered 
and the source was traced to portable suction pump. The risk of nosocomial infection was found 
to be directly related to the duration of stay in the Pediatric ICU and duration of placement of 
indwelling catheters /tubes 
7.  Herington  et al17conducted a study on the rate of surgical site infections and the frequency of 
various pathogens causing surgical site infection with their antibiotic resistance pattern in general 
surgery units in 190 patients admitted for surgery (clean and clean-contaminated elective cases) 
were assessed preoperatively, intraoperatively and postoperatively. Normal microbial flora was 
studied within 24 to 48 hours of admission and patients were followed up to 30 days 
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postoperatively. Infected wounds were studied bacteriologically and clinically. The overall 
infection rate was 8.95%. Surgical site infection rate was 3.03% in clean surgeries and 22.41% in 
clean-contaminated surgeries. Significant increase was seen in surgical site infection rate with an 
increase in preoperative stay. The increase in duration of surgery was associated with a 
significant rise in the rate of surgical site infection. Surgical site infection rate was much higher 
(22.41%) in cases where a drain was used than in non -drained wounds (3.03%). The most  
ommon isolate was  Staphylococcus aureus followed by Pseudomonas aeruginosa 
8.  Kirk et al18, conducted a study on the antibiotic sensitivity patterns. Most notable were the 
decreased sensitivities of Streptococcus pneumoniae to penicillin (96% to 63%), coagulase-
negative Staphylococcus to oxacillin (50% to 38%), and Pseudomonas aeruginosa  to amino  
glycosides [(gentamycin (85% to 64%), tobramycin (96%  to 83%), amikacin (92% to 74%)  and 
ciprofloxacin (85% to 69%). These decreased antibiotic sensitivities reflect increased bacterial 
selection     pressure as a result of widespread antibiotic use. The study concluded that a 
combined approach involving infection-control specialists, infectious disease physicians, and 
hospital administrators is necessary to address this increasingly difficult problem. 
9.  Riahi1 et al19conducted a study to assess changes in macrolide and ketolide resistance among 
Streptococcus pyrogenes in Europe and to examine the relationship of resistance to antimicrobial 
usage. Results: The erythromycin resistance rate during 2004–05 (11.6%) was similar to 2002–
03 (10.4%). The proportion of macrolide-resistant isolates increased from 29.3% (2002–03) to 
45.7% (2004–05). Telithromycin resistance increased from 1.8% in 2002–03 to 5.2% in 2004–
05. For Western Europe, associations of telithromycin and erythromycin resistance, respectively, 
were found with azithromycin use, clarithromycin use and total macrolide/lincosamide use. For 
Eastern Europe, associations of antimicrobial use with resistance were not apparent. The 162 
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telithromycin-resistantisolates with68.5%in eight major  groups. The erm gene was detected in 
155 of the 162 telithromycin-resistant isolates. Significant increases in telithromycin resistance 
occurred from 2002–03 to 2004–05 in Europe. Macrolide use appears to be a factor in the 
emergence of ketolide resistance among S.pyogenesin Western Europe. 
10.  Uwaezuoke et al20, conducted a survey of antibiotic resistant Staphylococcus aureus strains 
from clinical specimens was carried out. A total of 100 different clinical specimens were 
investigated with a yield of 48 Staphylococcus aureus isolates. A high resistance of 95.8% to 
penicillin, 89.6% to ampicilline, 87.5% to tetracycline, and 75.0% to chloramphenicol by 
Staphylococcus aureus strains were recorded.high susceptibility of 91.7% to gentamycin and 
85.4% to cloxacillin were also recorded. The high percentage resistance to the antibiotics studied 
attributed the prevailing usage and abuse in the area under study. The implication of the high 
percentage recorded for the antibiotics is that Staphylococcus aureus infections could be 
effectively treated with gentamycin and cloxacillin and not with penicillin, ampicilline, 
tetracycline, and chloramphenicol in the area under study.. 
11.  Hariharan  et al21conducted a study on antibiotic resistance patterns in the urgical intensive 
care unit (ICU) of a tertiary care university teaching hospital and the organisms reported were 
Enterobacteriaceae, Pseudomonas species, Staphylococcus aureus, and enterococci. Organisms 
were highly resistant to amoxicillin and first-generation cephalosporins because of the wide use 
of these drugs in the hospital. Pseudomonas species showed a 25% increase in resistance to 
piperacillin-tazobactam and an 18% increase to ciprofloxacin, which was correlated with the 
increased use of these antimicrobial agents (82% and 200% increases, respectively). This study 
provided data of antimicrobial resistance in a developing country with tourism as the main 
industry for epidemiologic comparison with other countries. 
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12.  Currie et al22assessed the prevalence of vancomycin-resistant enterococcal rectal 
colonization in a 750-bed hospital (including assessment of the impact of antibiotic use on 
prevalence) and to compare this method of surveillance to that of monitoring sterile body fluid  
cultures A rectal swab culture survey was conducted on a randomly chosen sample of 131 
patients who were stratified by prior antibiotic use.The study concluded that periodic rectal swab 
culture surveys were more sensitive in detecting the prevalence of  vancomycin-resistant 
enterococcal colonization and provided strategic information to guide infection control activities. 
And restriction of oral and parenteral vancomycin therapy as well as restriction of cephalosporin 
therapy (Cefoxitin, ceftriaxone, and ceftazidime) may contribute significantly to reducing the 
prevalence of vancomycin-resistant enterococcal colonization.. 
13.  AbulaT et al23,  assessed the pattern of antibiotic usage in surgical in-patients of a teaching 
hospital in north west of Ethiopia The average number of antibiotics and the mean duration of 
particularly prophylactic antibiotic therapy were some how increased. The use of antibiotics on 
empirical basis was a routine prescribing practice. The rationale of some antibiotic combinations 
required evaluation; and the establishment of antibiotic policy and treatment guidelines with 
periodic assessment of the sensitivity pattern of pathogenic organisms was recommended.  
14.  Salehi24 conducted a study designed to find the predominant pathogens and their 
antimicrobial resistance in a University    hospital intensive care unit. We obtained samples from 
patients who had no signs and symptoms of infection on admission in ICU but showed infection 
signs at least after 48 hours. Cultures were obtained and antibiogram tests were done. Thereafter 
appropriate antibiotics were administered. aution is responsible for antibiotic resistance. The 
study showed the necessity of prevention of infections with use of proper antibiotics. 
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15.  Ikeagwu IJ et al25,  conducted a study to investigate the sensitivity pattern of Staphylococcus 
aureus  isolates obtained from clinical specimens including urine, wound high vaginal swab and 
semen to commonly used antibiotics. The susceptibility patterns of these   isolates were 
determined    using the disc diffusion and agar well diffusion methods. Out of 174 samples, 51 
(29.2%) yielded Staphylococcus aureus with the highest isolation from semen (66.7%)    and for 
Ofloxacin (65%)    while the least was for Co- trimoxazole (6%). Amoxicillin, Ampicillin, 
Tetracycline and Cloxacillin recorded 37%, 19%, 8% and 11% respectively. The study 
recommends the use of Ofloxacin in the treatment of S.aureus infections in the study area. It also 
underscores the need for sensitivity testing before the administration of antibiotics for the 
treatment of Staphylococcal infections  
16.  Lari J et al26, conducted a   bacteriological study of 110 emergency appendicectomies. In 
two-thirds of these the    appendix was inflamed or gangrenous, and in 45 cases positive cultures 
were obtained    from swabs taken at operation. Bacteroides were found frequently in these 
swabs and    also in those taken from wound infections. Although this study is too small to draw   
any definite conclusions, it is felt that bacteroides should be considered an important    pathogen 
in appendicitis and should be taken into account in the few ill patients where    antibiotic 
treatment is contemplated. It was also noted that swabs taken from the      surface of the appendix 
itself were more often positive than those from the peritoneal    cavity, and this difference 
appears to be significant. 
17.  Shankar et al27, conducted a study to determine the prescribing frequency and rationality of 
use of antimicrobials. Here totals of 297 records of patients were admitted to the intensive 
treatment unit of the Manipal teaching hospital. About half (50.2%) of the patients received an 
antimicrobial; 84.6% of the antimicrobials were used without obtaining bacteriologic evidence of 
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infection. The commonest organisms isolated on culture were Pseudomonas aeruginosa, 
Klebsiella pneumoniae, Streptococcus pneumoniae, and Staphylococcus aureus. Prescriber 
education to improve prescribing patterns and regular auditing of antimicrobial prescriptions to 
prevent their inappropriate use and unnecessary cost to the patients is required. The high 
percentage of inappropriate use of antimicrobials raises concerns about the 
developmentandspread of drug resistance, which must be addressed. 
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3. NEED OF THE STUDY 
India has an enormous and growing problem in anti-biotic abuse. Infection of incised skin 
or soft tissue is a common but potentially avoidable complication of any surgical procedure. 
Some bacterial contamination of surgical site is inevitable, patient’s own bacterial flora or from 
the environment. 
It is considered as one of the most common nosocomial infection. The post operative 
complication has brought about considerable financial burden, undue discomfort to the patient, 
and sometimes even death. There has been an introduction of many antimicrobial agents in the 
market. This has lead surgeon to a wide range of antibiotics to choose from. Some of this 
antimicrobial agent is so effective that they invite complacency on the part of die attending 
surgeon so that no documentation of causative organism is made. Many troves found it 
convenient to shift from one kind of antibiotics to another prompt by transient clinical response 
followed by a recrudescence of the initial problem and ending up with the need to do culture and 
sensitivity testing only after a series of trial antibiotic treatment had been administered.  They 
have been responsible for the increasing cost, morbidity and mortality related to surgical 
operations and continues to be a major problem even in hospitals with most modern facilities and 
standard protocols of preoperative preparation and antibiotic prophylaxis.  The laboratory testing 
of antibiotic susceptibility contributes directly to patient care and the expertise of the 
microbiology laboratory can have powerful influence on antibiotic usage29. 
This practice is overshadowed by the fact that many investigations have showed the 
potential benefits of a more systematic recording of the causative factors which encouraged us to 
assess our local situations.   
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Surgical site infections rank third among nosocomial infections, representing a global 
threat, associated with the emergence of multi-drug-resistant bacteria.  
Monitoring institutional resistance patterns is vital in order to make required formulary 
changes in response to emerging resistance patterns and to determine the most effective agents 
given prevailing susceptibility patterns30. The study will be useful in reducing the incidence of 
surgical site infection, identify the operations for which routine prophylaxis is supported by 
evidence, minimize the effect of antibiotics on the patient's normal bacterial flora and minimize 
adverse effects and the antibiotics chosen for the prophylaxis can be those used for active 
treatment of infection and cause minimal change to the patient's host defenses.   
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4. AIM AND OBJECTIVES 
Aim 
Study was conducted   to determine the anti-biotic sensitivity pattern among the surgical cases in 
a tertiary  hospital in erode and use the result to format an antibiotic policy for the usage in the 
surgical wards of the hospital. 
Objectives 
To conduct survey on the surgeries conducted in the tertiary hospital in erode 
To study the antibiotics usage pattern in the surgical wards of tertiary hospital in erode 
To identify the common bacteria isolated from the surgical wound of the patients in the post 
operative wards of tertiary hospital in erode 
To analyze the antimicrobial activity pattern of the commonly used antibiotics in the surgical 
wards of tertiary hospital in erode 
To prepare an antibiotic policy for the antibiotic treatment in the surgical wards Tertiary Hospital 
in Erode, on the basis of the study findings. 
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5. METHODOLOGY 
1.  Study Site:     
Tertiary hospital in Erode among which 87 beds goes for the Surgical wards 
2.  Study Duration:  6 months study(march-2013 to august-2013) (tertiary hospital in erode). 
3.  Study design:     
Prospective observational study on the surgical patients for whom surgery was done  
4.  Study Criteria: 
a) Inclusion criteria 
Patient in the post operative wards after surgery. Presence of at least one of the following 
signs and symptoms of infection: pain or tenderness, localized swelling, purulent 
drainage site of incision, redness or heat and demonstration of infection on deliberate 
opening of the wound by a surgeon. 
b) Exclusion criteria  
Patients with non-willing to give the study sample 
5. Study Procedure  
a. The antibiotic usage survey in the surgical wards to be done. 
b. The patients who are satisfying the inclusion criteria will be enrolled after getting their 
signature or thumb impression in the informed consent form (ANNEXURE I).  
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c. The patient details were entered into the data collection form (ANNEXURE II) which 
included details such as: socio-demographic data (age and sex of the patient), clinical 
diagnosis, duration of hospitalization, drug data (drug name, dosage form, route and 
duration of therapy), basis of treatment (empirical or definitive), and other relevant 
information. Culture Sensitivity testing 
d. selection of patients based on the willingness and collection of swabs from the surgical 
sites of the patients using sterile Hiculture collecting device (Himedia). 
e. The collected incision swabs were then streaked into the previously prepared agar 
plates. The plates were then incubated for 24 hours at 320C. The antimicrobial sensitivity 
testing was carried out using standard techniques. 
f. The zones of inhibition around the antibiotic disc in the plates were measured using 
normal measuring scale. Thereby the antibiotic sensitivity level was measured. 
g. The data obtained will be recorded to develop an antibiotic policy for treatment in the 
surgical wards. 
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6. RESULTS 
The study was conducted in the post operative ward of the tertiary hospital in erode for a 
period of 6 months.  
6.1. Demographic details 
A total of 213 surgeries took place in the surgical wards during the study period of 6 
months. Among which 140 (65.72%) were male patients and 73 (34.27) were female patients 
who were admitted in the surgical wards (Fig 6.1). 
 
Fig 2 Percentage of surgical cases 
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6.3. Survey of Antibiotic usage. 
Figure 3.represents the percentage of antibiotic usage in surgical wards. The mostly used 
were Cefotaxime (29%), Metronidazole (13%), Ampicillin (13%), Ciprofloxacin (12%), 
Amoxycillin (12%), Gentamycin  (9%), Amikacin (4%),  Norfloxacin (3%),  Cephalexin (3%),  
and Ceftriaxone(1%). 
Fig  4.  Antibiotics usage in the surgical wards 
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6.5. Antibiotics usage in the cases where incision swab was taken 
Table 2 represents antibiotics prescribed in various surgical cases and Figure 5 represents the Percentage of antibiotics 
prescribed for the different surgical cases were collected. Mostly the antibiotics were given as prophylactics. The most prescribed 
antibiotics were Cefotaxime (25%), Metronidazole (12%), Ampicillin (12%), Amoxicillin (12%), Gentamycin (12%), Ciprofloxacin 
(9%), Ceftriaxone (6%), Norfloxacin (6%), Cephalexin (3%), and Amikacin (2%). 
Table 5. Antibiotics prescribed in various surgical cases where incision swabs were taken 
Diagnosis Antibiotics Prescribed 
Cefotaxime 
 
Ciprofloxacin 
 
Ampicillin 
 
Gentamycin 
 
Metronidazole 
 
Amoxicillin 
 
Ceftrioxane 
 
Amikacin 
 
Norfloxacin  
 
Cephalexin 
Hernioplasty      5 1 3 - 2 1 - - - -  
Appendicitis 3 1 3 1 2 1 1 1 - -  
Road traffic 
Accident        1 
1 
 - _2 - 2 
_ 
 
1 
 - 1 
Raw area 1 - - - - - - 1 2 2  
Gangrene Foot 1 1 - - - 2 - - - - 
Rectal trauma 
  1 - - - 2 - 
1 
 
- 
 - 
- 
 
Hydocele  
Absession  1 1 - 2 - - - - - 1 
Celluliti 1 - 2 2 - - - - - - 
Ulcer Foot 1 2 1 - 2 1 1 - -  
Thyroidectomy 1 - - 1 - 1 - 1 - -  
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Table.8. Drugs recommended based on our study  
 
 
 
 
 
 
 
 
 
S.No Diagnosis Doctor 
prescribed 
Present organisms Identified sensitive 
antibiotics 
1 Hernioplasty Cefotaxime Staphylococcus 
aureus,pseudomonas
Ciprofloxacin 
2 Road traffic 
Accident 
Amoxycillin 
Norfloxain 
Staphylococcus 
aureus  
streptococcus 
Ciprofloxacin 
3 Rectal trauma Metronidazole Staphylococcus Ciprofloxacin, 
Amoxycillin 
4 Hydocele 
Absession 
Gentamycin 
ciprofloxain 
E. coli Ciprofloxacin 
Metronidazole 
5 Raw area angle Amikacin, 
cefotaxime 
Streptococcus, 
E.coli 
Ciprofloxacin 
Metronidazole 
6 Cellulities Ampicillin, 
Gentamycin 
Streptococcus, 
pseudomonas 
Ciprofloxacin 
Metronidazole 
7 Ulcer food Ampicillin, 
Amoxycilllin 
Streptococcus  
E.coli 
Ciprofloxacin 
Metronidazole 
8 Thyroidectomy Amoxycillin 
Amikacin, 
cefotaxime 
Negative - 
 
9 Appendicitis Ciprofloxain 
Ampicillin(R), 
Metronidazole 
Streptococcus 
staphylococcus  
E.coli 
Ciprofloxacin 
metronidazole,Amoxycillin
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7. DISCUSSION 
From Tertiary Care Hospital in Erode totally 213 operations were conducted 
in surgical ward, among which the incision swab was collected for culture and 
sensitivity testing for 50 cases. Mainly 4 micro-organisms were identified and 
isolated, namely Staphylococcus aureus, Streptococcus, Escherichia coli and 
Pseudomonas. The study showed that some drugs prescribed in the hospital were 
resistant to the micro organism isolated. Here high preponderance of the aerobic 
bacteria was observed. 
The present study showed that the Staphylococcus aureus was the most 
common micro-organism isolated from the swab samples which was the most 
common cause for the surgical site infection. This study finding coincided with the 
results of the studies conducted by Siguan et al15and Giacometti et al14.  
The antibiotic sensitivity analysis showed that Ciprofloxacin to be highly 
sensitive antibiotic to all of the micro organisms isolated. Metronidazole was found to 
be highly sensitive to Escherichia-coli and Pseudomonas.  Amoxyllin was found to be 
medium sensitive to Staphylococcus aureus.  Gentamycin was found to be low 
sensitive to Pseudomonas. Ampicillin was found to be low sensitive to streptococcus. 
Ceftriaxone was found to be low sensitive to Staphylococcus aureus. 
In our study, the sensitivity pattern of antibiotics with respect to the different 
microorganisms in different cases were monitored The results were discussed in the 
table 6.4 and 6.5.  In the Tertiary Care Hospital, the physicians were commonly 
prescribed the antibiotics such as Cefotaxime, Metronidazole, Ampicillin, 
Amoxicillin, Gentamycin, Ciprofloxacin, Ceftriaxone, Norfloxacin, Cephalexin, and 
Amikacin. Based on our study, among the above antibiotics Ciprofloxacin and 
Metronidazole were found to as highly sensitive with all the selected four 
microorganisms.   
The result of this study clearly emphasizes that the magnitude of surgical 
wound infection problem may be increasing because of many of the causative 
organism have probably started to develop some form of resistance to the currently 
used antibiotics. The overall infection rate in this hospital was 6 % which is relatively 
high based on the generally acceptable surgical infection rate of 5 %. Undoubtedly 
efforts on infection on surveillance and control have become indispensable in a 
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hospital which values optimum patient care and which hopes to prevent the 
occurrence of surgical wound infection. Surveillance of surgical site infection with the 
feedback of appropriate data to surgeons would be desirable to reduce the surgical site 
infection  
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8. CONCLUSION 
From tertiary hospital in erode totally 213 operations were conducted in surgical ward 
of erode hospital Among which the incision swab was collected for culture and 
sensitivity testing for 50 cases. Mainly 4 micro-organisms were identified and 
isolated, namely Staphylococcus aureus, Streptococcus, Escherichia coli and 
Pseudomonas. The study showed that the micro organisms isolated from the swabs 
were resistant to some of the antibiotics prescribed in the hospital. The antibiotic 
therapy observed in the study was empirical. The various antibiotic sensitivity and 
resistance pattern of commonly used anti microbial agents were presented to show a 
changing trend towards unsatisfactory drug performance. The increasing rate of 
surgical site infection in  
This hospital should be seriously looked into before this pattern escalates into 
epidemic proportions. The development of effective control programs through 
adoption of measures that restrict use of specific antibiotics, establishment of 
therapeutic guideline, a constant monitoring of antibiotic resistant pattern of the 
common pathogenic organism in the hospital are recommended in order to improve 
the use of antibiotics. This information can guide surgeons in particular and 
physicians in general in the fight against surgical site infection. Only with this scheme 
we can sincerely offer patients a more optimistic outlook on their change of acquiring 
this post operative complication.   
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ANNEXURE - I 
 
INFORMED CONSENT FORM 
 
     I, ______________________________ exercising my free power of choice, 
hereby give my consent to be included as a patient in the clinical study “Study on the 
Anti-biotic Sensitivity Pattern in the Post Operative Wards of a Secondary Care 
Hospital in ===== 
 
I agree to the following: 
1. I understand that I will not be given any new study medication for 
participation in the study.   
2. I understand that, since I am already taking the drug as prescribed by doctor, I 
become eligible to be included in the study.   
3. I also understand that I may need to give blood samples on different days that 
will be used for the estmation.  This information will be correlated with my 
clinical progress by the doctor who will decide if I am receiving the right drug.   
4. I also understand that the information thus gathered will be helpful in 
optimizing my drug therapy.   
5. I have been informed to my satisfaction by the attending physician about the 
purpose of the clinical study and study procedures including the investigations 
to monitor and safeguard my body functions. 
6. I have been given a full explanation by the supervising doctor of the nature, 
purpose, likely duration of the study and about what I will be expected to do. I 
have fully understood the information sheet given to me. 
7. I have been given the opportunity to question the attending doctor on all the 
aspects of the study, and I have understood the advice and information as a 
result.   
8. I have informed to the doctor about all medications that I have taken in the 
recent past and those I am currently taking.  
9. I have not taken part in any investigational study for the past one month. 
10. I am also aware of my right to opt out of the study at any time without giving 
any reason for doing so. 
11. I hereby give permission for the doctors in charge of this study to release the 
information regarding or obtained as a result of the participation in the study 
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to Mr.------------- I understand that medical records that reveal my identity will 
remain confidential except that they will be provided as noted above or as may 
be required by law. 
 
------------------------------------------ 
Signature of the patient* with date 
 
------------------------------------------ 
Signature of the impartial witness* with date 
 
I confirm that I have explained the nature, purpose and possible hazards of the above        
study to _______________________________ 
 
------------------------------------------ 
Signature of the Investigator with date 
 
 * Signature of the impartial witness is required only if the patient is illiterate; 
Impartial witness will ensure that the patient information sheet and patient 
consent form were explained to the patient in a language understood by the 
patient. 
Name and address of the impartial witness____________________ 
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ANNEURE – II 
 
Patient Data Collection Form 
Name of the patient:                                              Age:     Sex:         
Weight:                          Height:                                   Employment. 
Clinical diagnosis: 
Co‐ morbid conditions: 
Drugs taken before admission(if any): 
Sl. No. Drug name and strength Dosage form Route of 
Administration 
Duration of 
therapy 
     
 
Surgical procedure: 
Surgery categorization:              Major                Minor 
Duration of hospitalization before surgery: 
Duration of hospitalization after surgery: 
Drug data 
Sl. No. Drug name and 
strength 
Dosage form Route of 
Administration 
Duration of 
therapy 
1. Pre surgical drug treatment 
  
 
 
   
2. Post surgical drug treatment 
  
 
   
 
Basis of treatment:     Empirical              Definitive 
Other relevant information: 
 
 
